ARID1a may be useful biomarker for immunotherapy

07:11 EDT 8 May 2018 | ecancermedicalscience

Functional loss of ARID1a, a frequently mutated tumour suppressor gene, causes deficiencies in normal DNA repair and may sensitise tumours to immune checkpoint blockade therapies, according to researchers from The University of Texas MD Anderson Cancer...

Original Article: ARID1a may be useful biomarker for immunotherapy


More From BioPortfolio on "ARID1a may be useful biomarker for immunotherapy"

Quick Search


Relevant Topics

Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...